Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match

Transplant Proc. 2002 Aug;34(5):1614-6. doi: 10.1016/s0041-1345(02)03044-0.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Combined Modality Therapy
  • Creatinine / blood
  • Female
  • Follow-Up Studies
  • Histocompatibility Testing*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Isoantibodies / blood
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Living Donors*
  • Male
  • Middle Aged
  • Plasmapheresis*
  • Racial Groups
  • Retrospective Studies
  • Tacrolimus / therapeutic use
  • Time Factors
  • United States

Substances

  • Immunoglobulins, Intravenous
  • Isoantibodies
  • Creatinine
  • Tacrolimus